Pharma needs medical sales representatives who are able to add value in an increasingly digital world
Under pressure to treat more patients in a shorter time, it’s hardly surprising that 93% of GPs in the UK report that their workload is impacting upon the quality of patient services. Yet despite the rise of instantly available digital information, the majority of healthcare professionals still prefer face-to-face interaction with a pharma company above any other channel.
That preference for meeting the sales rep runs deeper the longer an HCP and rep know each other, and when their interaction is based on aligned goals to improve patient outcomes. So why is that?
Read the article in full ‘The evolution of the sales representative‘.